Stockscreener 앱 받기
2.69
5.78%
-0.165
시간 외 거래:
2.67
-0.02
-0.74%
전일 마감가:
$2.855
열려 있는:
$2.73
하루 거래량:
1.47M
Relative Volume:
0.48
시가총액:
$63.44M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-1.6108
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
-14.87%
1개월 성능:
+6.32%
6개월 성능:
-74.33%
1년 성능:
-64.79%
1일 변동 폭
$2.54
$2.74
1주일 범위
$2.45
$3.00
52주 변동 폭
$1.89
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
2.69 | 69.73M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-01 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
INmune Bio stock holds steady as Raymond James reiterates Market Perform - Investing.com Nigeria
INmune Bio’s Promising Phase 2 MINDFuL Trial Results Set to Stir Alzheimer’s Market - StocksToTrade
INmune Bio’s Future: Buying, Holding, or Selling? - timothysykes.com
INmune Bio stock up as prostate cancer trial succeeds (INMB) - Seeking Alpha
Volume Profile Shows Strong Base for INmune Bio Inc.Target Return Focused Trade Insights Shared - metal.it
INmune Bio stock soars after prostate cancer trial meets endpoints By Investing.com - Investing.com Nigeria
INmune Bio's Novel NK Cell Therapy Shows Tumor Reduction in Advanced Prostate Cancer Trial - Stock Titan
When is INmune Bio Inc. stock expected to show significant growthFree Bull & Bear Market Updates - Jammu Links News
Is INmune Bio Inc. stock overvalued or undervaluedBuild wealth faster with expert stock selection - Jammu Links News
Is INmune Bio Inc. a growth stock or a value stockDiscover market opportunities with real-time data - Jammu Links News
How does INmune Bio Inc. compare to its industry peersUnlock powerful stock screening techniques - Jammu Links News
What institutional investors are buying INmune Bio Inc. stockBuild wealth faster with disciplined trading - Jammu Links News
What are the technical indicators suggesting about INmune Bio Inc.Build wealth with long-term growth strategies - Jammu Links News
How does INmune Bio Inc. generate profit in a changing economyConsistent triple-digit returns - Jammu Links News
What analysts say about INmune Bio Inc. stockTremendous gains - Jammu Links News
What are analysts’ price targets for INmune Bio Inc. in the next 12 monthsExplosive wealth accumulation - Jammu Links News
Published on: 2025-08-03 15:38:34 - Jammu Links News
What makes INmune Bio Inc. stock price move sharplyUnlock powerful trading alerts for success - Jammu Links News
What is INmune Bio Inc. company’s growth strategyAccelerated wealth building - Jammu Links News
What catalysts could drive INmune Bio Inc. stock higher in 2025Get expert insights on market-moving stocks - Jammu Links News
What drives INmune Bio Inc. stock priceDouble-digit growth - Jammu Links News
Is it the right time to buy INmune Bio Inc. stockFinancial News Planner Backed By Experts - jammulinksnews.com
INmune Bio Inc. May Be Forming Higher Low — Chartwatchers AlertReal Trader Watchlist of Hot Stocks Released - metal.it
Price Channel Expanding on INmune Bio Inc.’s ChartOversold Bounce Stock Play Ideas Gain Attention - metal.it
Inmune Bio Inc. shares fall 1.83% after-hours as the company prepares to report Q2 2025 financial results. - AInvest
INmune Bio Inc. to Host Conference Call on August 7, 2025 for Q2 Results and Corporate Update - Quiver Quantitative
INmune Bio Announces Q1 Earnings Call on August 7th, 2025 at 4:30 PM EDT. - AInvest
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th - The Manila Times
INmune Bio to Present Q2 2025 Financial Results and Key Clinical-Stage Updates on August 7 - Stock Titan
INmune Bio Inc. recovery potential after sell offRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Inmune Bio Inc. shares fall 4.75% after-hours following the release of a video detailing the MINDFuL trial. - AInvest
INmune Bio Releases Video on Alzheimer’s Trial Results - TipRanks
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference - The Manila Times
INmune Bio To Share New Alzheimer's Trial Results On YouTube After Major Conference Reveal - 富途牛牛
INmune Bio to Publish Video on MINDFuL Trial Findings for XPro™ Treatment at Alzheimer's Association International Conference. - AInvest
Breakthrough in Alzheimer's Treatment: Phase 2 Trial Reveals XPro Drug's Impact on Cognitive Decline - Stock Titan
How INmune Bio Inc. stock performs during market volatilityROI Driven Equity Selection With Safety Emphasized - metal.it
Trend Reversal Possible in INmune Bio Inc. Charts IndicateSwing Trade Entry With Volume Triggers Released - metal.it
Is INmune Bio Inc. Stock a Good Fit for Conservative InvestorsDaily Volume Spike Trading Signals Detected - metal.it
Alzheimer’s Breakthrough: INmune Bio’s XPro Trial Shows Promise in Subpopulation - StocksToTrade
INmune Bio Stock Soars 19.56% on Clinical Trial Success - AInvest
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge? - Benzinga
How many analysts rate INmune Bio Inc. as a “Buy”Achieve breakthrough profits with expert advice - Jammu Links News
New Product Launches: Will They Boost INmune Bio Inc. Stock in 2025Best Stocks for Capital Safety - metal.it
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.01%
자본화:
|
볼륨(24시간):